Biomarkers for Early Diagnostic of Mild Cognitive Impairment in Type-2 Diabetes Patients: A Multicentre, Retrospective, Nested Case–Control Study

Biomarkers for Early Diagnostic of Mild Cognitive Impairment in Type-2 Diabetes Patients: A Multicentre, Retrospective, Nested Case–Control Study

Background: Both type 2 diabetes mellitus (T2DM) and Alzheimer's disease (AD) are common age-associated disorders and T2DM patients show an increased risk to suffer from AD, however, there is currently no marker to identify who in T2DM populations will develop AD. Since glycogen synthase kinase...

Full description

Bibliographic Details
Main Authors: Zhi-Peng Xu, Su-Lian Yang, Shi Zhao, Cheng-Hong Zheng, Hong-Hua Li, Yao Zhang, Rong-Xi Huang, Meng-Zhu Li, Yuan Gao, Shu-Juan Zhang, Pei-Yan Zhan, Li-Fang Zhang, Lin Deng, Sheng Wei, Yan-Chao Liu, Jing-Wang Ye, Hu-Jun Ren, Na Li, Cai-Xia Kong, Xin Wang, Lin Fang, Qiu-Zhi Zhou, Hong-Wei Jiang, Jing-Rong Li, Qun Wang, Dan Ke, Gong-Ping Liu, Jian-Zhi Wang
Format: Article
Language:English
Published: Elsevier 2016-03-01
Series:EBioMedicine
Subjects:
Type 2 diabetes mellitus
Mild cognitive impairment
Alzheimer's disease
Glycogen synthase kinase-3β
Olfactory score
ApoE gene
Online Access:http://www.sciencedirect.com/science/article/pii/S2352396416300457

Internet

http://www.sciencedirect.com/science/article/pii/S2352396416300457

Similar Items